Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?
Status unconfirmed · Phase 3
Conditions studied: Shoulder Pain
In brief
The opioid epidemic continues to be a major concern, with orthopedic surgeons being among the top prescribers of opioids. Studies evaluating these practices found that opioids are overprescribed, even for common procedures. Patients undergoing arthroscopic labrum repair of the shoulder were found to have an average of 20 pills left over after surgery. Many strategies have been developed to tackle overprescribing and have found success, including no opioid protocols for carpal tunnel release. The purpose of this study is to examine if meloxicam alone provides similar patient reported outcomes to opioids following arthroscopic labrum repair of the shoulder.
Key facts
- Study ID
- NCT04725357
- Run by
- Rothman Institute Orthopaedics
- People needed
- 96
- Starts
- 2021-01-25
- Expected to finish
- 2022-01-25
- Last updated by the study team
- 2021-01-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age ≥ 18
- Scheduled for arthroscopic labrum repair of the shoulder
You may not qualify if…
- History of opioid, acetaminophen, NSAID or local anesthetic allergy or intolerance, or contraindications to these medications.
- Currently on long-term preoperative narcotics
- Scheduled for revision arthroscopic repairs of the shoulder
- Unable/unwilling to consent for enrollment
- Unable to complete postoperative surveys
- History of chronic pain syndromes (fibromyalgia, chronic diffuse MSK pain, etc)
- Patients under the age of 18
- Pregnant or breastfeeding women
- Scheduled for concurrent procedures
Where it is running
- Rothman Orthopaedic Institute — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.